Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients
Kawai, Taketo, Sato, Yusuke, Makino, Katsuhiro, Yamada, Yuta, Nomiya, Akira, Nakamura, Masaki, Yamada, Daisuke, Suzuki, Motofumi, Igawa, Yasuhiko, Kume, HarukiVolume:
116
Langue:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2019.05.017
Date:
July, 2019
Fichier:
PDF, 336 KB
english, 2019